Arrowhead Pharmaceuticals Inc

Financials

Fluxo de caixa operacional -137.22 M-146.27 M460.05 M-154.72 M20.49 M13.48 M 339.31 M Fluxo de caixa de investimento -222.92 M76.91 M-420.21 M141.39 M72.62 M-23.74 M -229.95 M Fluxo de caixa de financiamento 389.09 M20.63 M92.38 M-42.68 M3.67 M-14.75 M 38.62 M Fluxo de caixa livre -161.5 M-153.79 M454.76 M-157.08 M13 M11.33 M 322.01 M

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

ARWR

Financials

Arrowhead Pharmaceuticals Inc

Notícias

TD Cowen reitera classificação de compra para ações da Arrowhead Pharma

BofA reduz preço-alvo da Arrowhead Pharma devido a perspectivas de obesidade

Wave Life Sciences Crashes 55% As 'Body Composition' Fat-Loss Drug Underwhelms

Arrowhead Pharmaceuticals: Transition Phase With Moderate Upside Ahead (NASDAQ:ARWR)

Leerink reitera classificação das ações da Arrowhead Pharma após dados de parceira

Wolfe Research mantém classificação das ações da Ionis após estratégia de preços

Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies

SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study

Diretor médico da Arrowhead Pharmaceuticals vende US$ 641.900 em ações

Arrowhead Pharmaceuticals na conferência Leerink: insights estratégicos do pipeline/n

Arrowhead Pharmaceuticals at Leerink Conference: Strategic Pipeline Insights

Arrowhead Pharmaceuticals na Conferência TD Cowen: insights estratégicos em foco cardiometabólico